Partners in Digital Health

 

iNFORMATION FOR aUTHORS

TELEHEALTH AND MEDICINE TODAY



 Telehealth and Medicine Today is an open access e-journal published by Partners in Digital Health. Our goal is to assist healthcare decision makers in launching sustainable telehealth services within clinically integrated healthcare systems. To this end, Telehealth and Medicine Today offers rapid, peer reviewed publication of research and commentaries related to innovations in digital information and telecommunications technologies in patient centered care. Emphasis focuses on, but is not limited to, advances in program implementation and outcomes as a result of process improvement, advanced econometrics, and synergies that foster earlier interventions and advance value-based healthcare for the 21st century and future healthcare challenges.

AUDIENCE

Hospitals and medical research centers; payers; healthcare providers; medical directors; health economists; biopharm, biotech, and device companies; IT/IS; researchers; innovators; academicians; and all others with an interest in digital health and telemedicine will find content relevant to their interests in Telehealth and Medicine Today.

CRITERIA FOR PUBLICATION

Telehealth and Medicine Today applies rigorous editorial and peer review overseen by a team of professional editors and independent editor experts in the field.

Within the scope of the journal, as noted above, manuscripts should represent:

Originality and practicality in advancing telehealth and telemedicine
Importance to research, practice, or change in the field
Interest and relevance for those outside the audience
Rigorous methodology, with conclusions justified by the evidence presented
Adherence to the highest ethical standards

COMPETING INTERESTS

The Telehealth and Medicine Today editors are paid a fee for each review, Editors are required to declare all relevant competing interests and do not participate in the review of any submission for which they have a competing interest.

 OPEN ACCESS

Telehealth and Medicine Today applies the Creative Commons Attribution license to works we publish. This license was developed to facilitate open access – namely, free immediate access to, and unrestricted reuse of, original works of interest to the readers of Telehealth and Medicine Today.

Under this license, authors agree to make articles legally available for reuse, without permission or fees, for virtually any purpose. Anyone may copy, distribute, or reuse these articles, as long as the author and original source are properly cited.

SUBMISSION INFORMATION

To submit a new manuscript, please send your submission to the Managing Editor, John Russo Jr., PharmD, jr@medcomres.com
.

PEER REVEIW POLICY  

All manuscripts submitted for publication undergo peer review. 

ARTICLE TYPES

Original research: These are detailed studies reporting original research in which telemedicine has played a significant role. They include hypothesis, background study, methods, results, interpretation of findings, and a discussion of possible implications. Original research articles have a word count of up to 2500.

Review article: Review articles give an overview of existing literature, with emphasis on telemedicine, often identifying specific problems or issues and analyzing information from available published work on the topic with a balanced perspective. Review articles can be of three types: literature reviews, systematic reviews, and meta-analyses. Review articles have the maximum word limit of up to 3000.

Clinical case study: Clinical case studies present the details of real patient cases from medical or clinical practice in which telemedicine played a significant role. The cases presented are usually those that contribute significantly to the existing knowledge on the field. The study is expected to discuss signs, symptoms, diagnosis, and treatment of a disease. The word count is up to 1500.

Clinical trial: Clinical trials describe the methodology, implementation, and results of controlled studies in which telemedicine played a significant role. Word count is 2500.

Perspective, opinion, interview, and commentary: These are scholarly reviews of fundamental concepts or prevalent ideas in a field of telemedicine. A perspective piece can be a review of a single concept or a few related concepts. These are around 1000 words.

Book review: The aim of a book review is to provide insight and opinion on recently published scholarly books on telemedicine or related topic. These are not more than 1000 word.

Departments for articles

Research and Innovation
New Technologies and Companies
New Gamification and Behavior Modification Apps
New Products and Devices
Interviews and Opinions
Training Tools for Health Professionals and Patients
Policy and Regulation
Global News
Book Reviews

The Managing editor will assign the article to the relevant department.

 
ACCREDITATION STATEMENT  

Articles in Telehealth and Medicine Today that offer continuing medical education credit (CME) have been designated in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Essential CME Inc. and Partners in Digital Health. Essential CME Inc. is accredited by the ACCME to provide continuing medical education for physicians.


CREDIT DESIGNATION  

Essential CME Inc. designates CME-accredited articles for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 
DISCLOSURE OF UNLABELED USE

Articles published by Telehealth and Medicine Today may contain information and discussions of published and/or investigational uses of devices and agents that are not indicated by the Food and Drug Administrations (FDA). Essential CME Inc. and Partners in Digital Health do not recommend the use of any devices or agents outside of the labeled indications.

 Opinions expressed in articles designated for CME credit are those of the authors and do not necessarily represent the views of Essential CME Inc. or Partners in Digital Health.

AUTHOORSHIP AND RELATED INFORMATION 

Manuscripts should only be submitted for consideration once authorization of all contributing authors is gathered. The list of authors will include those who can legitimately claim authorship. This includes all those who:

Have made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data
Drafted the article or revised it critically for important intellectual content
Approved the version to be published

Authors will meet the conditions of all of the points above. Each author will have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information.

Patient consent

Authors will ensure the following guidelines are followed, as recommended by ICMJE, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.

Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is usually inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.

 
STATISTICAL ANALYSIS 

Ensure that the methodology has been accurately described for statistical analysis. In comparative studies power calculations are usually required. In research manuscripts requiring complex statistics the advice of an expert statistician should be sought at the design/implementation stage of the study. It may be appropriate to include them as a co-author.

If preparing statistical data for publication, please read the statistical guidelines.

Corresponding author contact details

Provide full contact details for the corresponding author including email, mailing address, and telephone numbers. Academic affiliations are required for all authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

PROOFS AND REPRINTS  

PDF proofs will be sent to the corresponding author, who should send corrections as soon as the PDF is received. These corrections should be returned to the Managing Editor, John Russo Jr., PharmD, jr@medcomres.com.

Order forms for reprints will be emailed to the corresponding author shortly before publication of the article.

Submitted manuscripts should be exclusive publication in the Telehealth and Medicine Today, with the understanding they have not been published elsewhere in any form and will not be submitted elsewhere unless rejected by the Telehealth and Medicine Today. Authors are responsible for all statements made in the article and the veracity of the references cited.

JOURNAL INFORMATION

Editorial and Peer Review Process

MANUSCRIPT STATUS

Authors can check the status of a manuscript at any time in the submission system. Authors will be notified by email when a decision is made.

CRITERIA FOR PUBLICATION  

Within the scope of the journal, manuscripts should represent a substantial advance in medical science or medical practice in terms of:

Originality and novelty
Importance to researchers or practitioners in the field
Interest in advancing value based medicine
Rigorous methodology with conclusions justified by the evidence presented
Adherence to the highest ethical standards

EDITORIAL PROCESS  

Telehealth and Medicine Today aims to provide all authors with an efficient, courteous, and constructive editorial process. To achieve its required level of quality, Telehealth and Medicine Today is selective with manuscripts that it publishes and anticipates rejection rates to be high, particularly since Telehealth and Medicine Today has a provisional CME accreditation.

NEW SUBMISSIONS  

It is essential that authors submit a presubmission inquiry before submitting a full manuscript. Presubmission inquiries allow authors to quickly find out whether their manuscript is likely to be broadly suitable for Telehealth and Medicine Today.

Responses are normally provided within 3 calendar days.

PEER REVEIW  

All articles, with the exception of editorials appearing in departments, are externally peer reviewed before a final decision about acceptance for publication. Expert reviewers are asked to assess the technical and scientific merits of the work. Where relevant, work presented in a manuscript undergoes a rigorous review of the statistical methods used. 

How are reviewers selected?

Telehealth and Medicine Today selects reviewers for a particular manuscript based on expertise, reputation, and specific recommendations of authors, as well as the Telehealth and Medicine Today editorial board’s knowledge of a reviewer.

Will authors know who is reviewing their manuscript?

Reviewers’ identities are anonymous unless a reviewer indicates otherwise.

Can authors exclude Editorial Board Reviewers or Independent Reviewers?

Upon submission of a manuscript, authors are asked if they wish to exclude any specific reviewers from the peer review of their article. The editorial team respects these requests when it does not interfere with the objective and thorough assessment of the article.

Once all reviews are received and considered, a decision letter to the author is drafted.

EDITORIAL DECISIONS  

Several types of decisions are possible. If after peer review a manuscript is considered potentially appropriate, a major revision is generally requested. A minor revision is generally requested as a final step before acceptance.

Manuscripts that are rejected generally do not fit the criteria outlined above in terms of originality, importance to the field, cross-disciplinary interest, or sound methodology.

REVISIONS 

Our Managing Editor and Primary Reviewer will assess revised manuscripts. Manuscripts that undergo major revision may require re-review or additional statistical review. There is no guarantee of acceptance after major revision.

APPEALS  

If you wish to appeal a decision contact the Managing Editor who handled the presubmission inquiry or full manuscript, explaining in detail your reasons for the appeal.

All appeals are discussed with at least one other reviewer and editorial board member. In the case of disagreement the appeal is discussed during a full editorial meeting. Telehealth and Medicine Today may seek external advice on the appeal at its option.

Second appeals are not considered.

ACCEPTED MANUSCRIPTS  

If your manuscript has been accepted, Telehealth and Medicine Today will send details and expected publish date along with all other relevant details.

If you have questions at any stage in the process, please email our Managing Editor, John Russo Jr., PharmD, jr@medcomres.com

PRESUBMISSION INQUIRIES 

It is essential that authors submit a presubmission inquiry before submitting a full manuscript. Presubmission inquiries allow authors to quickly learn whether their manuscript is likely to be suitable.

For other article types submit a short summary paragraph or bullet points.

FORMAT

Introduction

This section should describe clearly the rationale for the study. The final sentence should state the specific study hypothesis and/or study objectives.

METHODS

Describe the study participants or what was studied (e.g., patient population, cell lines; be as specific as possible, including numbers studied).
Describe the study design, intervention if applicable, main methods used, primary outcome measure(s), and length of follow up if applicable.
Describe what was primarily being assessed (e.g. primary outcome measure and, if appropriate, over what period).
Describe how results were analyzed (i.e., which specific statistical tests were used).

RESULTS

Include how many participants were assessed out of those enrolled. For survey research, include the response rate.
For the main outcomes provide a numerical result if appropriate (it nearly always is) and a measure of its precision (e.g. 95% confidence interval).
Describe all adverse events.
Describe the limitations of the study.
Integrate these findings into the current state of knowledge

CONCLUSIONS

Provide a general interpretation of the results with any implications supported by the research and important recommendations for future research.
For a clinical trial provide trial identification numbers and names (e.g., trial registration number, protocol number or acronym).

Best Practices in Research Reporting

Research submitted must comply with internationally accepted standards for research practice and reporting, including data management, figure preparation, reproducibility, and reporting guidelines.

Issues discovered after publication will be addressed according to guidelines of the Committee on Publication Ethics (COPE) and may lead to a correction, retraction, or expression of concern. Telehealth and Medicine Today may also contact authors’ institutions as appropriate.

Reporting Guidelines for Specific Study Types

Authors are expected to comply with standard reporting guidelines for study designs. Check the EQUATOR Network for reporting instructions and supporting documentation. Documentation for specific studies should be uploaded as supporting information during manuscript submission.

CLINICAL TRIALS

Clinical trial reports must adhere to the relevant reporting guidelines for their study design, such as CONSORT for randomized controlled trials, TREND for non-randomized trials, and other specialized guidelines as appropriate.

Systematic reviews and meta-analyses

Reports of systematic reviews and meta-analyses must adhere to the PRISMA statement as a guide, and include a completed PRISMA checklist and flow diagram to accompany the main text. Blank templates of the checklist and flow diagram can be downloaded from the PRISMA web site.

Authors must state within their Methods section whether a protocol exists for their systematic review, and if so, provide a copy of the protocol as Supporting Information.

We support the prospective registration of systematic reviews. Authors whose systematic review was prospectively registered (e.g., in a registry such as PROSPERO) should also provide the registry number in their abstract. Registry details and protocols will be made available to editors and reviewers, and included alongside the manuscript for readers if the report is ultimately published.

Diagnostic studies

Reports of studies of diagnostic accuracy should conform to the STARD requirements.

Competing Interests

What Represents a Competing Interest?

A competing interest is anything that interferes with, or is reasonably be perceived as interfering with the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to Telehealth and Medicine Today.

Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person.

Declaring all potential competing interests is required and integral to the transparent reporting of research.

Failure to declare competing interests can result in immediate rejection of a manuscript. If an undisclosed competing interest comes to light after publication, Telehealth and Medicine Today will take action in accordance with COPE guidelines and issue a public notification to the community. 

WHAT TO DECLARE 

All potentially competing interests (see below) must be declared if they occurred within 5 years of conducting, or preparing for publication, the research under consideration.

Interests outside the 5-year time frame must be declared if they can reasonably be perceived as competing according to the definition above.

Financial competing interests

Financial competing interests include but are not limited to:

Ownership of stocks or shares
Paid employment or consultancy
Board membership
Patent applications (pending or actual), including individual applications or those belonging to the institution to which the authors are affiliated and from which the authors may benefit
Research grants (from any source, restricted or unrestricted)
Travel grants and honoraria for speaking or participation at meetings
Gifts

NON-FINANCIAL COMPETING INTERESTS

Non-financial competing interests include but are not limited to:

Acting as an expert witness
Member of a government or other advisory board
Relationship (paid or unpaid) with organizations and funding bodies including nongovernmental organizations, research institutions, or charities
Membership of lobbying or advocacy organizations
Writing or consulting for an educational company
Personal relationships (i.e. friend, spouse, family member, current or previous mentor, adversary) with individuals involved in the submission or evaluation of a manuscript, such as authors, reviewers, editors, or members of the editorial board of a Telehealth and Medicine Today journal
Personal convictions (political, religious, ideological, or other) related to a manuscript's topic that might interfere with an unbiased publication process (at the stage of authorship, peer review, editorial decision-making, or publication)

WHO MUST DECLARE COMPETING INTERESTS?  

Authors: At the time of submission, authors will state relevant competing interests to the submitted research. These may include but are not limited to:

Names of all funding sources
Description of funder’s role in the study design; collection, analysis, and interpretation of data; writing of the manuscript; and/or decision to submit for publication
Whether they have served or currently serve on the editorial board of the journal to which they are submitting
Whether they have acted as an expert witness in relevant legal proceedings
Whether they have sat or currently sit on a committee for an organization that may benefit from publication of the manuscript

Editors and reviewers: Editors (professional or academic, paid or unpaid) and reviewers must declare their competing interests and if necessary disqualify themselves from involvement in the assessment of a manuscript.

Common reasons for editors and reviewers to recuse themselves from the peer review process may include but are not limited to:

They work at the same institution or organization as an author, currently or recently
They collaborate with an author, currently or recently
They have published with an author during the past 5 years
They have held grants with an author, currently or recently
They have a personal relationship with an author that does not allow them to evaluate the manuscript objectively

Readers: Anyone who comments on published articles must declare all competing interests (financial or non-financial) at the time of posting the comment.

Editorial Actions and Decisions

Telehealth and Medicine Today editors must take all competing interests into account during the review process and ensure that any relevant ones are declared in the published article.
Telehealth and Medicine Today editors will not publish commissioned or any other non-research articles if they are aware of a competing interest that, in their judgment, could introduce bias or a reasonable perception of bias.
Telehealth and Medicine Today editors do not consult reviewers who have competing interests that, in the editors' judgment, could interfere with unbiased review. 

DISCLOSURE OF FUNDING SOURCES

All authors are required to declare what support they received to carry out their research. Declaring funding sources acknowledges funders’ contributions, fulfills funding requirements, and promotes greater transparency in the research process.

We support GPP2 Good Publication Practice for Communicating Company Sponsored Medical Research.

WHAT TO DECLARE 

Each author must individually declare all sources of funding received for the research submitted to the journal. This information includes the name of granting agencies, grant numbers, and a description of each funder’s role. If the funder has played no role in the research, this must be stated as well.

Authors are not required to provide the complete list of every grant that supports them if the grant is not related to the research published

FUNDING STATEMENT  

A Funding Statement is included in the metadata of each published article. The Funding Statement includes the funding information declared by the authors.

Inaccurate information about funding discovered after publication may require correction. 

HOW TO DECLARE 

Funding information is entered in the online submission system.

 
CONTENT LICENSE  

The Creative Commons Attribution license to works we publish. This license was developed to facilitate open access – namely, free immediate access to, and unrestricted reuse of, original works of all types.

Under this license, authors agree to make articles legally available for reuse, without permission or fees, for virtually any purpose. Anyone may copy, distribute or reuse these articles, as long as the author and original source are properly cited.

DATA

If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than Creative Common.

Submitting Copyrighted or Proprietary Content

All figures, photos, tables, or other works previously copyrighted or containing proprietary data must be accompanied by written permission from the copyright holder to use that content. This includes:

Maps and satellite images
Slogans and logos
Social media content

DATA AVAILABILITY

Telehealth and Medicine Today requires authors to make all data underlying the findings described in their manuscript fully available without restriction.

When submitting a manuscript online, provide a Data Availability Statement describing compliance with Telehealth and Medicine Today policy. If the article is accepted for publication, the data availability statement will be published with the final article.

Refusal to share data and related metadata and methods in accordance with this policy is grounds for rejection. Telehealth and Medicine Today editors encourage researchers to contact them if they encounter difficulties in obtaining data from articles published. If restrictions on access to data come to light after publication, Telehealth and Medicine Today reserves the right to post a correction, to contact the authors' institutions and funders, or in extreme cases to retract the publication.

If authors did not collect data themselves but used another source, this source must be credited as appropriate. Authors with questions or difficulties with the policy, or readers who have difficulty accessing data, are encouraged to contact the Telehealth and Medicine Today Managing Editor.

 

FAQS

My study uses proprietary data; what should I do?

Telehealth and Medicine Today considers proprietary data to be data owned by commercial interests, or copyrighted data that the data owners will not share (e.g., data from a pharmaceutical company that will share the data only with regulatory agencies for purposes of drug approval, but not with researchers).

 Telehealth and Medicine Today does not consider submissions where the conclusions depend solely on the analysis of proprietary data, whether these data are owned by the authors, by their funders or institutions, or by other parties. If proprietary data are used and cannot be accessed by others (in the same manner by which the authors obtained it), the manuscript must include an analysis of public data that validates the conclusions so that others can reproduce the analysis and build on the findings.

CLINICAL DATA

My study analyzes qualitative data and the participants did not consent to have their full transcripts made publicly available. What should I do?

The data policy exception related to privacy concerns pertains in this case. However, if requested, at least the excerpts of the transcripts relevant to the study must be shared. In this case, authors should include the contact information where requests may be sent in their Data Availability Statement, and state that excerpts of data are available on request. If even sharing excerpts would violate the agreement to which the participants consented, please inform the relevant journal office.

My study was conducted in humans and my minimum data set includes information on individuals. What should I do?

Data must never breach patient confidentiality. Authors must ensure that the data shared are in accordance with patient consent. Authors should provide only the data that are used in the specific study.

The following may not be appropriate to include depending on what other information is provided:

place of treatment or health professional responsible for care;
gender;
rare disease or treatment;
sensitive data, such as illicit drug use or risky behavior;
place of birth;
socioeconomic data, such as occupation or place of work, income, or education household;
family composition;
anthropometric measures;
number of pregnancies;
ethnicity;
year of birth or age;
verbatim transcripts or responses.

Also potentially inappropriate to include, depending on the type of information provided, are data on population sizes of less than 100 or those with small numerators (e.g., event counts less than 3). (Information from Hrynaszkiewicz I, Norton M L, Vickers A J, Altman D G. (2010). Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. BMJ 340:c181. http://www.bmj.com/content/340/bmj.c181.long)

DEPOSITING DATA 

What if I cannot provide accession numbers or DOIs for my data set at submission?

If this is the case, authors may submit their manuscript and note in their Data Availability Statement that their accession numbers or digital object identifier (DOI) will not be made available until acceptance. Telehealth and Medicine Today will contact you at acceptance to provide this information, and will delay acceptance until Telehealth and Medicine Today receives these identifiers for your data set.

Providing ‘private’ access for reviewers and editors during the peer review process is acceptable. Many repositories permit private access for review purposes, and have policies for public release at publication.

Is Telehealth and Medicine Today integrated with any repositories?

Telehealth and Medicine Today has a Data Repository Integration Partner Program that integrates our submission process with partner data repositories to better support data sharing and author compliance. The Telehealth and Medicine Today submission system is integrated with partner repositories to ensure that the article and its underlying data are paired, published together, and linked. The integration facilitates deposition of data alongside article submission, which may also facilitate consideration and peer review of submissions.

How do I deposit data with a data repository integration partner?

Once an author deposits data in the integrated repository, s/he receives a provisional data set DOI along with a private reviewer URL link. Upon submission to Telehealth and Medicine Today authors must include the data DOI into the Data Availability Statement. They should also provide the reviewer URL, which will permit restricted access to the data during peer review. If a manuscript is accepted, the publication of the article and public release of the data set will be automatically coordinated.

What are acceptable licenses for my data deposition?

Data should be covered by a Creative Commons license or a less restrictive license.

Submitting to Telehealth and Medicine Today

What is the data availability statement and what should I write?

Upon submission to Telehealth and Medicine Today e-journal, authors are asked to enter the location and availability of their data. This will be published should the manuscript be accepted.

If data are freely available, Telehealth and Medicine Today asks that authors note this and state the location of their data:

 What format should I use for my data?

The file format used to submit data should follow the standards in the field. If there are currently no standards in the field, submit the data in an accessible format from which data can be efficiently extracted (e.g., Excel rather than PDF).

How do I submit data as supporting information files?

Upon submission and at revision, authors have the opportunity to upload supporting information files.

MATERIALS AND SOFTWARE SHARING  

SHARING MATERIALS

Telehealth and Medicine Today expects that all researchers submitting manuscripts will make all relevant materials that may be reasonably requested by others available without restrictions upon publication of the work.

Editors and reviewers should verify the availability of materials during the peer review process, and contact the journal if any restrictions are discovered.

Telehealth and Medicine Today cannot arbitrate disputes among authors and peer review participants, especially in terms of Materials Transfer Agreements (MTAs). 

SHARING SOFTWARE  

Telehealth and Medicine Today expects that all researchers’ submissions in which software is the central part of the manuscript will make all relevant software available without restrictions upon publication of the work. Authors must ensure that software remains usable over time regardless of versions or upgrades. If the original software cannot be shared, authors must provide a reasonable facsimile.

Software manuscripts: Software submitted must meet the following requirements:

Based on open source standards
Conform to the Open Source Definition
Deposited in an open software archive (see “Depositing software,” below)
Included in the submission as supporting information
Linked directly from the manuscript file

Depositing software: The following items must be deposited in an open software archive:

The associated source code of the software described in the manuscript. This should, as far as possible, follow accepted community standards and be licensed under a suitable license such as BSD, LGPL, or MIT (see the full list of suitable licenses). Dependency on commercial software such as Mathematica and MATLAB does not preclude a manuscript from consideration, although complete open source solutions are preferred. The code should be easy to locate and download without creating user accounts, logging in, or entering other personal details.
Documentation for running and installing the software. For end-user applications, instructions for installing and using the software are prerequisite; for software libraries, instructions for using the application program interface are prerequisite.
A test dataset with associated control parameter settings. Where feasible, results from standard test sets should be included. Where possible, test data should not have any dependencies — for example, a database dump.

Software archives: Archives should provide a public repository of the described software. The repository must have been in existence for over five years or be hosting more than 1,000 projects.

Reviewing software manuscripts: A software manuscript is considered for publication if it covers a well-established project that has been providing an open source code repository for an extended amount of time.

In order for a software manuscript to be considered for publication, editors, reviewers, or readers must be able to:

Access the public version of the software
Reproduce the results
Run the software on the deposited dataset with the provided control parameters

Only one hardware-software platform is required. The platform must be in common use by the readership (e.g., MATLAB).

Software manuscripts will not be considered under the following circumstances:

They require access to databases or other resources whose persistence is not guaranteed (e.g., individual laboratory databases without funding support)
Running the software depends on proprietary or otherwise unobtainable ancillary software

ETHICAL PUBLISHING PRACTICE  

OVERVIEW

Telehealth and Medicine Today abides by COPE, its Code of Conduct, and aims to adhere to its Best Practice Guidelines.

Authors, editors, and reviewers are expected to be aware of, and comply with, best practice in publication ethics.

Authors are expected to be aware of, and comply with, best practice in publication ethics specifically but not limited to authorship (e.g., avoidance of ghost or guest authorship), dual submission, plagiarism, manipulation of figures, competing interests and compliance with policies on research ethics. Details are provided below or in related documents
Reviewers and editors are required to treat manuscripts fairly and in confidence, and declare any competing interests.

Telehealth and Medicine Today will vigorously investigate allegations of research or publication misconduct and Telehealth and Medicine Today reserves the right to contact authors’ institutions, funders or regulatory bodies if needed.

In cases of suspected or alleged misconduct, Telehealth and Medicine Today will follow the COPE flowcharts and may also seek advice at the COPE forum. If Telehealth and Medicine Today finds conclusive evidence of misconduct Telehealth and Medicine Today will take steps to correct the scientific record, which may include issuing a correction or retraction.

If you have any concerns about potential misconduct, please email the journal. Address correspondence to the journal’s Managing Editor jr@medcomres.com.

Additional resources on publication ethics are available from COPE and WAME.

AUTHORSHIP

Everyone listed as an author should meet our criteria for authorship. Everyone who meets the Telehealth and Medicine Today criteria for authorship must be listed as an author.

The contributions of all authors must be described. Author lists should accurately reflect contributions to the work and we expect that all authors will take public responsibility for the content of the manuscript submitted to Telehealth and Medicine Today.

All authors will be contacted by email at submission to ensure they are aware of and approve the submission of the manuscript, its content, and authorship. All authors must see the final draft of the manuscript before it is published.

Contributors not meeting the criteria for authorship should be mentioned in the Acknowledgments.

Authorship issues identified after publication may result in a correction in the case of an authorship dispute, the journal will not arbitrate. Telehealth and Medicine Today will raise the issue with the authors’ institution(s) and abide by its guidelines.

Qualifying for authorship: Authorship criteria is based on the International Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

The ICMJE lists four conditions for authorship credit. Authors must meet all four conditions in order to be listed.

Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data
Drafting the article or revising it critically for important intellectual content
Final approval of the version to be published
Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved

Group authorship: The ICMJE recommends that group authorship adhere to the following guidelines:

When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship/contributorship defined above, and editors will ask these individuals to complete journal-specific author and conflict-of-interest disclosure forms. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. The NLM indexes the group name and the names of individuals the group has identified as being directly responsible for the manuscript; it also lists the names of collaborators if they are listed in Acknowledgments.

 
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.

Corresponding author responsibilities: The corresponding author takes responsibility for and speaks on behalf of all authors.

The corresponding author is responsible to ensure all authors have access to the final version of the manuscript that is submitted to the journal.
In the event that a member of the author group requests a change to the author list after submission, the corresponding author will provide written confirmation that all other others consent to the change.

Professional medical writers: The involvement of any professional medical writer in the publication process must be declared. The European Medical Writers' Association Guidelines contain additional information about the role of medical writers.

Changing author lists: Telehealth and Medicine Today follows the COPE guidelines for changes in authorship.

Changing the author list after submission requires agreement from all authors. The request must come from the corresponding author along with an explanation for the change. If the change is deemed to be appropriate, and the corresponding authors receives consent to the change from all other others, the journal will contact the individual to be added or removed from the list.

Editor and reviewer requirements: Editors should be aware of the author list and author affiliations when they invite reviewers to review a manuscript in order to reduce the likelihood of inviting individuals with potentially competing interests that would disqualify them from participating in the peer review process.

Editors and reviewers should contact Telehealth and Medicine Today with concerns about the author list or if they identify any potentially competing interests that should be declared or require they recuse themselves from the process.

PLAGIARISM

Plagiarism is not acceptable in Telehealth and Medicine Today submissions. Plagiarized content will not be considered for publication. If plagiarism is identified, Telehealth and Medicine Today will follow COPE guidelines.

If plagiarism is detected during the peer review process, the manuscript may be rejected. If plagiarism is detected after publication, Telehealth and Medicine Today may issue a correction or retract the article, as appropriate.

Telehealth and Medicine Today expects that editors and reviewers will be vigilant in their evaluation of submissions and will notify the journal about any plagiarism identified.

CONFIDENTIALITY

Telehealth and Medicine Today is committed to ensuring the integrity of the peer review process, in accordance with COPE guidelines. All submitted material should be treated as strictly confidential until published.

The peer review process is confidential to all parties. Correspondence as part of the review process is also to be treated confidentially by all parties, including authors.

Authors may provide basic details about the nature of the research presented in manuscripts currently under review.

Editors and reviewers are required to treat all submitted manuscripts in strict confidence and not share information about submissions with any other parties unless previously agreed by the Telehealth and Medicine Today managing editor. Involvement of a third party in the review must be declared at the time of the submission of the review.

Telehealth and Medicine Today expects that editors and reviewers will not make use of any material or take advantage of any information they gain through the peer review process.

Telehealth and Medicine Today will follow up on any and all breaches of confidentiality. If there are any concerns about misconduct during the review process, we will follow COPE guidelines in investigating them.

ANONYMITY

Reviewers may identify themselves by signing their names at the time reviews are submitted if they wish.

SUBMISSION AND PUBLICATION OF RELATED STUDIES

Author requirements: Upon submission of a manuscript, authors must indicate whether there are any related manuscripts under consideration or published elsewhere. If related work has been submitted or published elsewhere, authors must include a copy of it with their submission and describe its relation to the submitted work.

Prior publication of research as a thesis, presentation at medical or scientific conferences, or posting on preprint servers will not preclude consideration of your manuscript.

Editor and reviewer requirements: Reviewers and editors should evaluate any related content and notify Telehealth and Medicine Today of overlap. Editors and reviewers should alert Telehealth and Medicine Today if they identify duplicate submissions or publications during the review process.

Policy enforcement: If related content is found to be too similar to the Telehealth and Medicine Today submission, or if a duplicate submission is discovered, Telehealth and Medicine Today will reject the manuscript.

Duplicate content discovered after publication will be addressed depending on the degree of overlap. Telehealth and Medicine Today may issue a correction or a retraction as appropriate.

FIGURE PREPARATION

Image files should not be manipulated or adjusted in any way that could lead to misinterpretation of the information present in the original image.

BIOSECURITY AND DUAL USE RESEARCH OF CONCERN

Telehealth and Medicine Today recognizes that certain research may fall into the category of “dual use research of concern.” This is defined by the NSABB as any "biological research with legitimate scientific purpose that may be misused to pose a biologic threat to public health and/or national security."

As an Open Access publisher, Telehealth and Medicine Today remains committed to the widespread dissemination of research while being sensitive to the issues of responsible publication standards. In this context, Telehealth and Medicine Today assesses the risks and benefits of the research. If the risks outweigh the benefits, Telehealth and Medicine Today will not consider the research for publication.

Author requirements: Authors are obligated to disclose potential bioethics/dual use concerns to the journal office at the time of initial submission.

Editor and reviewer requirements: Editors and reviewers are expected to evaluate potential risks and alert the journal with any concerns.

POLICY ENFORCEMENT

Telehealth and Medicine Today follows standards set by national and public agencies and works with these agencies to verify potential risks.

Manuscripts are checked at submission for potential risks. Issues identified at submission may lead to rejection of the manuscript.

If risks are identified after publication of an article, Telehealth and Medicine Today will take steps to minimize that risk in accordance with prevailing guidelines. Telehealth and Medicine Today will follow up with authors’ institutions depending on the severity of the issues.

PUBLICATION FEES

$1,500 USD


Fees are per article and are billed upon acceptance. There are no additional charges.